Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor

Calcified Tissue International

Volumn 62, Issue 1, 1998, Pages 60-66

  Kassem, M ^a   Okazaki, R ^a   Harris, S A ^a   Spelsberg, T C ^a   Conover, C A ^a   Riggs, B L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bone; Estradiol; Osteoblast; PCR

Indexed keywords

CYCLIC AMP; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; HYDROXYTAMOXIFEN; MESSENGER RNA; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; SOMATOMEDIN;

ARTICLE; BONE; CELL LINE; CONTROLLED STUDY; FETUS; GENE EXPRESSION; HORMONE ACTION; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BUCLADESINE; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FORSKOLIN; GENE EXPRESSION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; OSTEOBLASTS; POLYMERASE CHAIN REACTION; POLYUNSATURATED ALKAMIDES; PROGESTERONE CONGENERS; PROMEGESTONE; RECEPTORS, ESTROGEN; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TIME FACTORS; UP-REGULATION;

EID: 0031985268     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900395     Document Type: Article

References (40)

1. Daughaday WH, Rotwein P (1989) Insulin-like growth factors I and II peptide. messenger ribonucleic acid and gene structure, serum and tissue concentrations. Endocr Rev 10:68-91
2. McCarthy TL, Centrella M, Canalis E (1992) Constitutive synthesis of insulin-like growth factor-II by primary osteoblast-enriched cultures from fetal rat calvariae. Endocrinology 130:1303-1308
3. Kassem M, Blum W, Risteli J, Mosekilde L, Eriksen EF (1993) Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int 52:222-226
4. Kanzaki S, Baxter RC, Knutsen R, Baylink DJ, Mohan S (1995) Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions. J Bone Miner Res 10:854-858
5. Wergedal JE, Mohan S. Lundy M, Baylink DJ (1990) Skeletal growth factors and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells. J Bone Miner Res 5:179-186
6. Hock JM, Centrella M, Canalis E (1988) Insulin-like growth factor I has independent effect on bone matrix formation and cell replication. Endocrinology 122:254-260
7. Ebeling PR, Jones JD, Janes CH, Lane AW, O'Fallon WM, Riggs BL (1992) Short-term effects of recombinant human insulin-like growth factor-I on bone turnover in normal women. J Clin Endocrinol Metab 77:1384-1387
8. Owens PC, Gill PC, De Young NJ. Knowles SE, Moyse KJ (1993) Estrogen and progesterone regulate secretion of insulin-like growth factor binding proteins by human breast cancer cells. Biochem Biophys Res Commun 193:467-473
9. Murphy LJ, Ghhary A (1990) Uterine insulin-like growth factor-I: regulation of expression and its role in estrogen-induced uterine proliferation. Endocr Rev 11:443-453
10. Ernst M, Rodan GA (1991) Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control. Mol Endocrinol 5:1081-1089
11. Ernst M, Heath JK, Rodan GA (1989) Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I. and parathyroid hormonestimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125:825-833
12. Ernst M, Schmid C, Froesch ER (1988) Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci 85:2307-2310
13. Okazaki R, Conover CA, Harris SA, Spelsberg TC, Riggs BL (1995) Normal human osteoblast-like cells consistently express genes for insulin-like growth factor I and II but transformed human osteoblast cell lines do not. J Bone Miner Res 10:788-795
14. Mohan S, Baylink DJ (1993) Characterization of the IGF regulatory system in bone. Adv Exp Med Biol 343:397-406
15. Hassager C, Fitzpatrick LA, Spencer EM, Riggs BL, Conover CA (1992) Basal and regulated prevention of insulin-like growth factor binding protein in osteoblast-like cells is cell line specific. J Clin Endocrinol Metab 75:228-233
16. McCarthy TL, Centrella M, Canalis E (1990) Cyclic AMP induces insulin-like growth factor I synthesis in osteoblastenrichcd cultures. J Biol Chem 265:15353-15356
17. Keeting PE, Scott RE, Colvard DS, Han IK, Spelsberg TC, Riggs BL (1991) Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells. J Bone Miner Res 6:297-304
18. Davis VL, Couse JF, Gray TK, Korach KS (1994) Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like cell lines. J Bone Miner Res 9:983-991
19. Harris SA, Enger RJ, Riggs BL, Spelsberg TC (1995) Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10:178-186
20. Harris SA, Tau KR, Enger RJ, Toft DO, Riggs BL, Spelsberg TC (1995) Estrogen response in the hFOB 1.19 human fetal osteoblastic cell line stably transfected with the human estrogen receptor gene. J Cell Biochem 59:193-201
21. Nakhla AM, Khan MS, Romas NP, Rosner W (1994) Estradiol causes the rapid accumulation of cAMP in human prostate. Proc Natl Acad Sci USA 91:5402-5405
22. Aronica SM, Kraus WL, Katzencllenbogen BS (1994) Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517-8521
23. Okazaki R, Durham SK, Riggs BL, Conover CA (1995) Transforming growth factor-β and forskolin increase all classes of insulin-like growth factor-I transcripts in normal human osteoblast-like cells. Biochem Biophys Res Commun 207:963-970
24. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
25. Chen D, Magnuson V, Hill S, Arnaud C, Steffensen B, Klebe RJ (1992) Regulation of integrin gene expression by substrate adherence. J Biol Chem 267:23502-23506
26. Chelly J, Kahn A (1994) RT-PCR and mRNA quantitation. In: Mullis KB, Ferre F, Gibbs RA (eds) The polymerase chain reaction. Birkhauser, Boston, pp 97-109
27. Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, Carbone PP, DeMets DL (1992) Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326:852-856
28. Turner RT, Wakley GK, Hannon KS, Bell NH (1987) Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats. J Bone Miner Res 2:449-456
29. Webb P, Lopez GN, Uht RM, Kushner PJ (1995) Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogen. Mol Endocrinol 9:443-456
30. McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW (1995) Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9:659-669
31. Tremollieres FA, Strong DD, Baylink DJ, Mohan S (1992) Progesterone and promogestone stimulate human bone cell proliferation and insulin-like growth factor-2 production. Acta Endocrinol 126:329-337
32. Chen D, Klebe RJ (1993) Controls for validation of relative reverse transcription-polymerase chain reaction assays. PCR Methods Appl 3:127-129
33. Kassem M, Okazaki R, DeLéon D, Harris SA, Robinson JA, Spelsberg TC, Conover CA, Riggs BL (1996) Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4. Proc Assoc Am Physicians 108:166-164
34. Umayahara Y, Kawamori R, Watada H, Imano E, Iwama H, Morishima T, Yamasaki Y, Kajimoto Y. Kamada T (1994) Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-I enhancer. J Biol Chem 269:16433-16441
35. Cho H, Katzenellenbogen BS (1993) Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol Endocrinol 7:441-452
36. Steiniche T, Hasling C, Charles P, Eriksen EF, Mosekilde L, Melsen F (1989) A randomized study on the effects of estrogen/ gestangen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone 10:313-320
37. Heaney RP, Recker RR, Saville PD (1978) Menopausal changes in bone remodeling. J Lab Clin Med 92:964-970
38. Ho KK, Weissberger AJ (1992) Impact of short-term estrogen administration on growth hormone secretion and action: dis-tinct route-dependent effects on connective and bone tissue metabolism. J Bone Miner Res 7:821-827
39. Weissberger AJ, Ho KK, Lazarus L (1991) Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I. and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72:374-381
40. Gray TK, Flynn TC, Gray KM, Nabell LM (1987) 17βEstradiol acts directly on the clonal osteoblastic cell line UMR 106. Proc Natl Acad Sci USA 84:6267-6271